Purification, characterization and immobilization of an NADPH-dependent enzyme involved in the chiral specific reduction of the keto ester M, an intermediate in the synthesis of an anti asthma drug, Montelukast, from Micobacterium campoquemadoensis (MB5814)

Applied Microbiology and Biotechnology

Volumn 49, Issue 6, 1998, Pages 709-717

  Shafiee, A ^a   Motamedi, H ^a   King, A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONTELUKAST; OXIDOREDUCTASE;

ARTICLE; BIOTRANSFORMATION; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME IMMOBILIZATION; GEL ELECTROPHORESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MICROORGANISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STEREOSPECIFICITY; TECHNIQUE;

EID: 0031864423     PISSN: 01757598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002530051236     Document Type: Article

References (15)

1. Anderson L, Mansson MO, Mosbach K (1987) Overview. In: Colowick SP, Kaplan NO (eds) Methods Enzymol. Academic Press Inc., New York, pp 117
2. Cusak M, Beynon RJ (1989) Protein purification and application. A practical approach. In: Harris ELV, Angal S (eds) IRL, Oxford, pp 264-266
3. Dordick JS (1991) Principle and application of nonaqueous enzymology. In: Blanch HW, Clark DS (eds) Applied biocatalysis. Dekker. New York, pp 1-52
4. Heimbuch BM, Gagliardi MM, Shafiee A, Chen T, Garity GM (1994) Characterization of a Microbacterium sp. producing a chiral specific keto-reductase. In: Annual Meeting of the Society of Industrial Microbiologists, Boston, USA
5. Hummel W, Kula MR (1989) Dehydrogenases for the synthesis of chiral compounds. Eur J Biochem 184: 1-13
6. King AO, Corely EG, Anderson RK, Larsen RD, Verhoeven TR, Reider PJ, Xiang YB, Belley M, Leblane Y, Labelle M, Prasit P, Zamboni RJ (1993) An efficient synthesis of LTD4 antagonist L-699,392. J Org Chem 58: 3731-3735
7. Klibanov AM, Cambou B (1987) Enzymatic production of optically active compounds in biphasic aqueous-organic systems. In: Colowick SP, Kaplan NO (eds) Methods Enzymol. Academic Press Inc. New York, pp 117-137
8. Matsumae H, Douno H, Yamada S, Nishida T, Ozaki Y, Shibatani T, Tosa T (1995) Microbial reduction of (RS)-2-(4-methoxyphenyl)-1,5-benzothiazepin-3,4(2H,5H)-dione, the key intermediate in the synthesis of dilitiazem hydrochloride. J Ferment Bioeng 79: 28-32
9. Motamedi H, Shafiee A, Cai SJ (1995) Integretive vectors for heterologous gene expression in Streptomyces spp. Gene 160: 25-31
10. Nassenstein A, Hemberger J, Schwartz H, Kula MR (1992) Studies on the enzymatic reduction of N-BOC-4S-amino-3-oxo-5-phenylpentanoic acid methylester. J Biotechnol 26: 183-201
11. Peters J, Zellinski T, Kula MR (1992) Studies on the distribution and regulation of microbial keto ester reductases. Appl Microbiol Biotechnol 38: 334-340
12. Roberge C, King A, Pecore V, Greasham R, Chartrain M (1996) Asymmetric bioreduction of a keto ester to its corresponding (S)-hydroxy ester by Microbacterium sp. MB5614. J Ferment Bioeng 81: 530-533
13. Tanaka A, Tosa T, Kobayashi T (1993) Industrial applications of immobilized biocatalysts. Dekker, New York
14. Ward OP, Young ES (1990) Reductive biotransformation of organic compounds by cells or enzymes of yeast. Enzyme Microb Technol 12: 483-493
15. Woodley JM, Lilly MD (1992) Process engineering of two-liquid phase biocatalysis. In: Tramper J, Vermude MH, Beeftink HH, Stockar U von (eds) Biocatalysis in non-conventional media. Elsevier Science, New York, pp 147-154